TIMP2 and breast cancer: Low TIMP2 expression levels in BC vs. benign and control tissues have been previously reported [118], [119], indicating that TIMP2 down-regulation with abundant MMP activation, represents a mechanism of tumor invasion and could be used as a novel prognostic indicator in BC.